Cellular retinol binding protein II (CRBP II) is a vitamin A-binding protein that is expressed specifically in small intestinal villus absorptive cells. Previous studies have shown that retinoic acid upregulates endogenous human CRBP II gene expression in differentiated Caco-2 cells. To better characterize the regulation of human CRBP II expression, we analyzed the ability of receptor-selective agonists to enhance transcription from the 5Ј-upstream flanking region of the human CRBP II gene. Stable transfection experiments showed that the proximal 2.8-kb region of the human CRBP II gene is sufficient for retinoic acid inducibility in differentiated Caco-2 cells. However, direct sequence analysis and transient transfection experiments indicate that, unlike the rat CRBP II promoter, the human CRBP II promoter is not a direct retinoid X receptor target. The results indicate that the retinoic acid responsiveness of the human CRBP II promoter is mediated by an indirect mechanism and that this mechanism is associated with enterocyte differentiation. gene regulation; retinoid X receptor; vitamin A; Caco-2 cells CELLULAR RETINOL BINDING PROTEIN II (CRBP II) is an abundant (0.4-1.0%) intestinal cytosolic protein that binds all-trans-retinol and all-trans-retinal (19, 20, 29) . In adult animals, expression of CRBP II is restricted to villus-associated enterocytes in the proximal small intestine (5). The intestine-specific localization of CRBP II suggests that it is uniquely adapted for intestinal absorption and/or metabolism of retinol. The human colonic adenocarcinoma Caco-2 cell line develops into a polarized epithelium after reaching confluence. The cells express proteins characteristic of both enterocytes and colonocytes immediately after reaching confluence (9, 30), but with increasing time after confluence, the expression of enterocytic proteins become more prominent (9). Human CRBP II expression increases after human Caco-2 cell monolayers become confluent and undergo differentiation (17, 31). Because postconfluent differentiated Caco-2 cell monolayers express human CRBP II and lecithin/retinol acyl transferase, they have been used to study intestinal vitamin A uptake and metabolism (11, 17, 22, 31, 38) . Stably transfected differentiated Caco-2 cells overexpressing CRBP II have increased uptake and esterification of all-transretinol (17, 22) . Treatment of postconfluent, differentiated Caco-2 cells with all-trans-retinoic acid, 9-cisretinoic acid, arachidonic acid, or its analog 5,8,11,14-eicosatetraynoic acid (ETYA) in serum-free medium further increases endogenous CRBP II mRNA levels (11, 38). Nuclear run-on experiments confirmed that the increase observed with ETYA and 9-cis-retinoic acid was due to increased transcription (11). These ligand studies suggest that retinoid X receptors (RXRs) are involved in the regulation of human CRBP II genes either as homodimers or partnered with other nuclear receptors such as the peroxisomal proliferator-activated receptors (PPARs).
gene regulation; retinoid X receptor; vitamin A; Caco-2 cells CELLULAR RETINOL BINDING PROTEIN II (CRBP II) is an abundant (0.4-1.0%) intestinal cytosolic protein that binds all-trans-retinol and all-trans-retinal (19, 20, 29) . In adult animals, expression of CRBP II is restricted to villus-associated enterocytes in the proximal small intestine (5) . The intestine-specific localization of CRBP II suggests that it is uniquely adapted for intestinal absorption and/or metabolism of retinol. The human colonic adenocarcinoma Caco-2 cell line develops into a polarized epithelium after reaching confluence. The cells express proteins characteristic of both enterocytes and colonocytes immediately after reaching confluence (9, 30) , but with increasing time after confluence, the expression of enterocytic proteins become more prominent (9) . Human CRBP II expression increases after human Caco-2 cell monolayers become confluent and undergo differentiation (17, 31) . Because postconfluent differentiated Caco-2 cell monolayers express human CRBP II and lecithin/retinol acyl transferase, they have been used to study intestinal vitamin A uptake and metabolism (11, 17, 22, 31, 38) . Stably transfected differentiated Caco-2 cells overexpressing CRBP II have increased uptake and esterification of all-transretinol (17, 22) . Treatment of postconfluent, differentiated Caco-2 cells with all-trans-retinoic acid, 9-cisretinoic acid, arachidonic acid, or its analog 5,8,11,14-eicosatetraynoic acid (ETYA) in serum-free medium further increases endogenous CRBP II mRNA levels (11, 38) . Nuclear run-on experiments confirmed that the increase observed with ETYA and 9-cis-retinoic acid was due to increased transcription (11) . These ligand studies suggest that retinoid X receptors (RXRs) are involved in the regulation of human CRBP II genes either as homodimers or partnered with other nuclear receptors such as the peroxisomal proliferator-activated receptors (PPARs).
The nuclear hormone receptors, including the RXRs, PPARs, and retinoic acid receptors (RARs) act via cis-acting DNA response elements (24) . The response elements consist of direct repeats (DR) of two consensus sequences [5Ј-RG(G/T)TCA or a closely related sequence] separated by a spacer varying in length from one to five nucleotides. The response elements for RXR homodimers (RXRE) and RXR-PPAR heterodimers (PPRE) consist of direct repeats that are separated by a single base pair (i.e., DR1). RXR-RAR heterodimers bind to response elements (RAREs), which consist of direct repeats separated by two (DR2) or five (DR5) nucleotides.
The rat CRBP II promoter contains a RXRE consisting of five nearly perfect tandem repeats of the consensus sequence separated by a single nucleotide ( Fig. 1) and is upregulated by retinoic acid only in the presence of RXR (25) . This element also binds PPAR-RXR het-erodimers and could potentially also serve as a PPRE (14, 38) . The rat CRBP II promoter also contains two more proximal response elements, termed RE2 and RE3, which correspond to DR2 and DR1 elements, respectively. The rat CRBP II RXRE is not conserved in the mouse CRBP II promoter. Instead, the mouse CRBP II promoter contains a truncated cis-acting element consisting of only two direct repeats separated by a single nucleotide, which was termed RE1 (28) . However, both RE2 and RE3 are conserved (28) .
When proliferating undifferentiated Caco-2 cells were transfected with a mouse CRBP II promoter [chloramphenicol acetyltransferase (CAT) reporter gene], there was no retinoic acid inducibility of CAT activity even after cotransfection with an RXR expression vector. The rat RXRE/thymidine kinase (tk)-CAT construct was also not responsive to retinoic acid when transiently transfected into preconfluent undifferentiated Caco-2 cells. However, cotransfection with an RXR expression vector restored retinoic acid inducibility. These results are consistent with observations that RXR-␣ levels increase with Caco-2 cell differentiation (39) .
To further investigate transcriptional regulation of CRBP II, we cloned and sequenced 2.8 kb of the 5Ј-flanking region of the human CRBP II gene to determine whether it contains a cis-acting element similar to the rat CRBP II RXRE. We also studied retinoic acid inducibility of reporter constructs incorporating this segment of the human CRBP II promoter in transiently transfected undifferentiated Caco-2 cells and in stably transfected differentiated Caco-2 cells.
METHODS
Cell culture. COS-1 and Caco-2 cells from the American Type Culture Collection were maintained at 37°C, 5.5% CO 2 in Dulbecco's modified Eagle's medium, 2 mM glutamine, 0.1 mM nonessential amino acids, 100 U/l penicillin, 100 g/ml streptomycin, and 10% heat-inactivated fetal calf serum. Caco-2 cells were subcultured as described previously (17) , and COS-1 cells were plated at 1 ϫ 10 4 cells/cm 2 . The me- dium was changed every other day for preconfluent cells. Medium was changed daily to maintain postconfluent Caco-2 monolayers.
Effects of RAR and RXR agonist administration. Differentiated Caco-2 cell monolayers (14 days postconfluent) in T-25 flasks were washed with serum-free medium supplemented with 6 mM Na taurocholate, 10 mM HEPES, and ITS premix (final concentration: 5 g/ml insulin, 5 g/ml transferrin, and 38.8 nmol/l selenious acid) as described previously (11) . The monolayers were then incubated for 24 h with ligand at 1 mol/l or vehicle alone (0.022 M ethanol). The medium was removed, and the monolayers were washed with PBS and immediately harvested. The RXR-selective agonist 4-[ (3,5,5,8,8- . Although all-trans-retinoic acid is a RARspecific agonist, when administered to cells it rapidly undergoes isomerization to 9-cis-retinoic acid, which is an agonist for both RXR and RAR.
Northern blot analysis and RT-PCR. Cells were scraped in TRIzol reagent (GIBCO-BRL, Grand Island, NY), and total RNA was isolated according to the manufacturer's recommendation based on improvements to the single-step RNA isolation method developed by Chomczynski and Sacchi (3) . Northern blots were prepared and probed with radiolabeled cDNAs. The membranes were washed once with 1ϫ SSC (0.15 M NaCl and 0.015 M sodium citrate)-0.1% SDS for 15 min at 25°C, once with 1ϫ SSC-0.1% SDS for 15 min at 25°C, and twice with 0.1ϫ SSC-0.1% SDS for 15 min at 65°C. The following cDNA probes were used: rat CRBP II cDNA (19) , human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA (17) , and enhanced green fluorescent protein (EGFP) cDNA (11) . The membranes were exposed to a PhosphorImager screen overnight. Signals were scanned and quantitated on a Storm PhosphorImager (Molecular Dynamics). The signal densities were normalized with respect to the GAPDH mRNA signal.
Endogenous human CDX2 gene expression in Caco-2 cells was assessed by semiquantitative RT-PCR using specific primers designed from different exons as described previously (8, 23) . As an internal standard, RT-PCR was carried out with primers for actin. The primers for PCR amplification were as follows: human CDX2, forward primer 5Ј-CCCG-GCGGCCAGCGGCGGAACCTGT-3Ј, reverse primer 5Ј-GTC-TAGCAGAGTCCACGCTCCTCAT-3Ј; actin, forward primer, 5Ј-GACTTCGAGCAGGAGATGGCCAC-3Ј, reverse primer 5Ј-CTCCTGCTTGCTGATCCACATC-3Ј.
Single-stranded cDNA was synthesized for 1 h at 42°C in 25 l containing 2 g RNA, 0.5 g oligo(dT) 15 , 100 units Maloney murine leukemia virus RT RNase H Ϫ point mutant (Promega, Madison, WI), 0.4 mM each dNTP, 50 mM Tris ⅐ HCl (pH 8.3), 75 mM KCl, 7 mM MgCl2, 10 mM dithiothreitol, and 0.1 mg/ml bovine serum albumin. To amplify endogenous CDX2 cDNA, PCR reactions (50 l) contained 5 l of cDNA solution, 4 pmol primers, 10 mM dNTP, 1 units Taq polymerase (Promega), 10 mM Tris ⅐ HCl (pH 9), 50 mM KCl, 0.01% Triton X-100, 1.5 mM MgCl2, and 1 M betaine. To amplify actin, 0.1 l of cDNA was used and betaine was omitted from the reaction. Conditions were: 94°C, 30 s; 55°C, 30 s; and 72°C, 45 s. For each primer, the reactions were performed for 28-45 cycles to overlap the range of cycles in which the amount of PCR product increased exponentially. The RT-PCR fragments were loaded on 2% agarose and analyzed by imaging densitometry (Eagle Eye II; Stratagene, LaJolla, CA). In addition, the fragments were cloned and sequenced to confirm their identity.
Cloning and analyzing the 5Ј-flanking genomic sequences of human CRBP II. A human P1 bacteriophage library was screened using PCR (Genome Systems, St. Louis, MO). Assuming that the intron/exon organization of human CRBP II gene would be similar to the mouse and rat Crbp II genes, the forward primer 5Ј-GCCACCCCCAAGATTGCA-3Ј and reverse primer 5Ј-CATGCCGGTTGTCCAGGC-3Ј were designed to generate a 163-bp product within exon 2 (corresponding to nucleotides 85-247 of the cDNA). Positive clones were then screened with the 32 P-5Ј-end-labeled antisense oligonucleotide 5Ј-CCATTCTGGTCCCTCGTCAT-3Ј corresponding to nucleotides 1-20 of the cDNA. The positive P1 clone was partially mapped by restriction enzyme digestion. A 5.5-kb probe-positive HindIII fragment was cloned into the HindIII site of pBluescript II KSϩ (Stratagene, La Jolla, CA) to generate plasmid pKSCPII. The 5Ј-flanking region in pK-SCPII was sequenced on an ABI prism sequencer (PerkinElmer Biosystems) using the dye terminator method.
The transcriptional start site was mapped by 5Ј-rapid amplification of cDNA ends (RACE) (2) using the SMART RACE cDNA amplification kit (Clontech, Palo Alto, CA) and following the manufacturer's recommendation. The firststrand cDNA synthesis was accomplished by reverse transcription of total RNA isolated from 14 day-postconfluent Caco-2 cells using a modified Moloney murine leukemia virus RT, SuperScript II RNase H Ϫ RT (Life Technologies, Rockville, MD), and the SMART II oligonucleotide and a modified oligo(dT) primer supplied by the kit. The 5Ј-cDNA fragment was amplified by PCR using the SMART II oligonucleotide as the 5Ј-primer and the antisense gene-specific primer 5Ј-TCACTTCTTTTTGAACACTTGAC-3Ј as the 3Ј-primer and was cloned. The transcriptional start site was determined by sequencing nine clones.
Transient transfection assays. A 2.8-kb human CRBP II promoter fragment (bp Ϫ2,742-ϩ58) was generated by PCR amplification of pKSCPII using the forward primer 5Ј-ATC-CTCGAGTCAGCATAATGTCTGTGAGA-3Ј and the reverse primer 5Ј-ATCAAGCTTTGGCCACTGGTTCGGTGA-3Ј. The amplified fragments were digested with XhoI and HindIII and subcloned into the XhoI and HindIII sites of the promotorless pGL2 luciferase reporter vector (Promega) to form the phCRBP II Ϫ2,742-ϩ58 -luc reporter construct for transient transfections. The RXR expression vector and the parental vector pEF-BOS (27, 32) were obtained from Dr. Daniel Kelly (Washington University, St. Louis, MO). The pCRBPIIϫ2RXRE tk-luciferase plasmid was a generous gift from Dr. Ozato (National Institute of Child Health and Human Development, Bethesda, MD) and was used as a control reporter construct for the RXR cotransfection experiments. It was constructed by placing two copies of the rat pCRBP II-RXRE DNA element upstream of the tk sequence (26), which in turn was inserted in the pGL2-Basic vector (Promega). The expression vectors for mouse Cdx2 (pRc-Cdx-2), mouse Cdx1 (pRc-Cdx-1), the control vector pRcCMV, and the Ϫ183HSILuc luciferase reporter construct have been previously described (40, 41) . Ϫ183HSILuc contains the evolutionarily conserved sucrase isomaltase gene promoter (Ϫ183-ϩ54 bp). The ␤-galactosidase expression vector pEF1/V5-His/LacZ (Invitrogen, Carlsbad, CA) was used as an internal control for transfection efficiency.
COS-1 cells (1 ϫ 10 5 ) or Caco-2 cells (4 ϫ 10 5 ) were plated in six-well tissue culture plates and maintained for 24 h in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal calf serum. The cells (at 40-60% confluence) were transfected using Fugene 6 (Roche, Indianap-olis, IN) according to the manufacturer's instructions, with 0.5 g of reporter plasmid, 1 g of expression vector (expression vector and control vector total), and 1 g of the ␤-galactosidase expression vector pEF1/V5-His/LacZ (Invitrogen).
Twenty hours after transfection, the medium was changed to a serum-free medium containing either 1 M all-transretinoic acid or vehicle (ethanol) alone. After an additional 24 h, the cells were washed twice with PBS and harvested with lysis buffer supplied with the luciferase assay kit (Promega). Luciferase activity was assayed on a Monolight luminometer (Pharmingen) according to the manufacturer's instructions. ␤-Galactosidase activity was assayed as described by Rosenthal (33) . The luciferase activity was normalized against the ␤-galactosidase activity. Transfections were performed in triplicate for each construct, and the results were expressed as the average fold induction over the pGL2-Basic vector.
Stably-transfected Caco-2 cells. The 2.8-kb human CRBP II (bp Ϫ2,742-ϩ58) promoter fragment was generated by PCR amplification as described in Transient transfection assays. The 5Ј-serial deletions of this promoter, human CRBP II (bp Ϫ745-ϩ58), human CRBP II (bp Ϫ150-ϩ58), and human CRBP II (bp Ϫ103-ϩ58), were generated by PCR amplification using the forward primers 5Ј-CCGCTCGAGCTCCCTCCAG-GCTCAGCTTGC-3Ј, 5Ј-CCGCTCGAGTACTGGATGAAATGT-TCTGTG-3Ј, and 5Ј-CCGCTCGAGTTGTGCTTCTGCCCTTTG-3Ј, respectively. The PCR fragments were subcloned into the XhoI and HindIII sites of pEGFP-1 (Clontech) to generate phCRBP II ) were plated in six-well plates and were transfected 24 h after plating using Fugene 6 with 2 g of the reporter constructs. Following removal of the DNA, fresh medium was added and the cells were incubated for 24 h at 37°C. Twenty-four hours after transfection, the cells were subjected to selection in G-418-supplemented media (0.8 mg/ml active drug). The medium was replaced with fresh G-418-supplemented medium every 3 days. Frozen stocks of pooled G-418-selected cells were prepared after 4 wk of selection.
Fluorescence microscopy. Stably transfected Caco-2 cells were plated on chamber slides and grown until 7 days after confluence in G-418-supplemented medium (0.8 mg/ml). The slides were washed with PBS and fixed in 2% formaldehyde-0.2% glutaraldehyde in PBS for 10 min at room temperature and then washed twice with PBS. The cells were mounted in VectorMount permanent mounting media (Vector Laboratories, Burlingame, CA) and observed by fluorescence microscopy using a Zeiss Axiostop 2 microscope.
RESULTS

Human CRBP II levels in postconfluent differentiated Caco-2 cells are upregulated by a RXR-specific agonist but not by a RAR-specific agonist.
Endogenous human CRBP II expression increases dramatically after Caco-2 cells reach confluence. RXR binds only 9-cisretinoic acid, and RAR binds both 9-cis-retinoic acid and all-trans-retinoic acid (24) . It has previously been shown that retinoic acid upregulates human CRBP II expression and retinol uptake by postconfluent differentiated Caco-2 cells (11). Since both 9-cis-retinoic acid and all-trans-retinoic acid rapidly undergo isomerization within the cell, these compounds cannot be used to distinguish between RXR-and RAR-mediated upregulation. Synthetic receptor-selective agonists, such as the RXR-specific agonist LG-1069 (1) and the RARspecific agonist TTNPB (4), were used for determining which receptors mediate retinoic acid inducibility of the human CRBP II promoter. We found that there was a two-to threefold upregulation of human CRBP II mRNA levels (Fig. 2) when Caco-2 cell monolayers were incubated with 1 M LG-1069. However, no significant increase was observed when the monolayers were incubated with 1 M TTNPB. These results suggest that the upregulation observed with all-transretinoic acid and 9-cis-retinoic acid is mediated by RXRs and not by RARs.
Comparison of the human CRBP II 5Ј-flanking sequence with that of the mouse and rat CRBP II genes. A P1 bacteriophage clone containing both exon 1 and exon 2 sequences of the human CRBP II gene was isolated. A 5.5-kb HindIII fragment containing exon 1 was subjected to partial restriction enzyme analysis (Fig. 1A) . Sequence analysis revealed that this fragment contained 2,857 nucleotides upstream of exon 1. To map the human CRBP II transcription start site, 5Ј-RACE experiments were carried out as described in METHODS. A cDNA fragment that was ϳ450 bp in size was amplified and cloned. The 5Ј-nucleotide in seven of the nine clones was a cytidine, and the 5Ј-nucleotide in two of the nine clones was the subsequent nucleotide, which was a thymidine (Fig. 1B) . On the basis of this analysis, we have designated the cytidine at position ϩ1 as the transcriptional start site. Comparisons of the proximal human CRBP II promoter sequences with the mouse and rat CRBP II promoter sequences reveal a high degree of sequence conservation in the 5Ј-flanking region between nucleotide Ϫ352 and the transcriptional start site at position ϩ1 (Fig. 1B) . The TATA box and the transcriptional start site are conserved across all three species. Motifs 1-4 corresponding to the 5Ј-RG(G/T)TCA or related motifs that form the response elements RE2 and RE3 in the rat and mouse promoters are contained within the proximal region of the promoter that is highly conserved across species (Fig. 1B) . However, neither RE2 nor RE3, which are conserved in the mouse and rat CRBP II promoters, are conserved in the human CRBP II promoter. The human sequence corresponding to that of the mouse and rat RE3 differs by a single A 3 C base change in motif 3, which has previously been shown to impair retinoic acid inducibility of promoter activity and to abolish both RXR-RXR homodimer and RXR-RAR heterodimer binding (25) . There are also changes in motif 4, but the changes result in a sequence that corresponds to the 5Ј-TGA(C/ A)CR-3Ј motif. The sequences corresponding to the mouse and rat CRBP II RE1 lie more distal to the region of high sequence homology. Alignment of the sequences could not detect an RE1 element in human CRBP II promoter (Fig. 3B) . Although Suruga et al. (38) reported that a RXRE could be amplified by PCR from the human CRBP II gene, an equivalent sequence could not be found within 2.8 kb upstream of exon 1 by direct sequence analysis.
The 2.8-kb human CRBP II promoter does not contain a functional RARE. To investigate whether functional RAREs are present in the human CRBP II 5Ј-flanking region, the reporter plasmid phCRBP II Ϫ2,742-ϩ58 -luc was cotransfected in undifferentiated Caco-2 cells or COS-1 cells, with either the parental expression vector pEF-BOS or the RXR-␣ expression vector. There was no significant retinoic acid induction of luciferase expression in either Caco-2 cells or COS-1 cells cotransfected with the phCRBP II Ϫ2,742-ϩ58 -luc reporter construct and the parental expression vector pEF-Bos. Cotransfection of the RXR-␣ expression vector did not confer retinoic acid inducibility to the phCRBP II Ϫ2,742-ϩ58 -luc reporter construct ( Table 1 ). The pCRBPIIϫ2RXRE tk-luciferase construct, which contains two copies of the RXRE from the rat CRBP II promoter, was used as a positive control. Similar to the results reported by Nakshatri and Chambon (28) for their rat RXRE/tk-CAT reporter construct, no retinoic acid induction of luciferase activity was observed when this vector was cotransfected with the parental expression vector pEF-BOS in either Caco-2 cells or COS-1 cells. However, when cotransfected with the RXR-␣ expression vector, retinoic acid induction of luciferase activity was observed in both cells. These results are consistent with the observation that the RXRE in the rat CRBP II promoter is not conserved in the human CRBP II promoter.
There are two potential explanations for why retinoic acid induction of the human CRBP II luciferase construct was not observed in transiently transfected undifferentiated proliferating Caco-2 cells. Since human CRBP II mRNA levels are barely detectable in proliferating undifferentiated Caco-2 cells (11), it is possible that differentiation of the Caco-2 cells is associated with alterations in the levels of other transactivating nuclear factors that regulate the human CRBP II promoter activity. Alternatively, an RXRE similar to the rat CRBP II RXRE may be located beyond 2.8 kb of exon 1 in the human CRBP II promoter. -EGFP-1 but not in 7-day-postconfluent, differentiated Caco-2 cells stably transfected with the promotorless vector pEGFP-1 (Fig.  3) . In preconfluent, differentiated Caco-2 cells stably transfected with phCRBP II-EGFP-1 as well as the promoterless vector pEGFP-1, the fluorescence was barely detectable (Fig. 3) . Fluorescence was observed, although at a lower intensity, in postconfluent Caco-2 cells, which were transfected with the phCRBP II
Ϫ103-ϩ58
-EGFP-1 construct (Fig. 3) .
To compare the retinoic acid inducibility of the 2.8-kb fragment of the proximal human CRBP II promoter with the endogenous human CRBP II gene, human CRBP II, EGFP-1, and human GAPDH mRNA levels were measured in differentiated 14-day-postconfluent, differentiated Caco-2 cells stably transfected with the phCRBP II Ϫ2,742-ϩ58 -EGFP-1 construct. Northern blot analyses demonstrated that retinoic acid treatment induced a fourfold increase in EGFP-1 mRNA levels and a threefold increase in endogenous human CRBP II mRNA levels (P Ͻ 0.02; n ϭ 3; Fig. 4 ). Thus this 2.8-kb segment of the human CRBP II promoter recapitulates the retinoic acid response of the endogenous human CRBP II gene in differentiated Caco-2 cells.
Retinoic acid upregulation of the CRBP II promoter could potentially occur via an indirect mechanism. The caudal-related homeodomain transcription factor Cdx1 has been implicated in transducing the retinoic acid effect on Hox gene transcription (13) . Both the caudalrelated homeodomain transcription factors Cdx1 and Cdx2 play important roles in intestinal gene expression and intestinal epithelial cell differentiation (7, 14, COS-1 and undifferentiated Caco-2 cells were cotransfected with the retinoid X receptor (RXR) expression vector as described in MATERIALS AND METHODS. The luciferase activity of the reporter cotransfected with the pEF-BOS in the absence of ligand is taken as 1. The basal level of phCRBPII
Ϫ2742-ϩ58
-luc was 20-fold and 70-fold higher than that of the promotorless pGL2 vector in Caco-2 cells and COS-1 cells, respectively. The basal level rat pCRBPIIϫ2RXRE thymidine kinase-luciferase was 20-fold and 40-fold higher than that of pGL2 in Caco-2 cells and COS-1 cells, respectively. The results are the average (Ϯ 15%) of 3 independent triplicated transfections. CRBP, cellular retinol binding protein; RA, retinoic acid 35). In Caco-2 cells, human CDX1 expression is barely detectable, and human CDX2 is the predominant caudal-related homeodomain transcription factor (23, 41) . CDX2 levels increase shortly after Caco-2 cells reach confluence (10, 43) . Cdx2 binding elements have been identified in the gene promoters of enterocytic genes, including sucrase isomaltase, lactase-phlorizin hydrolase, carbonic anhydrase 1, calbindin-D 9k , and clusterin (6, 10, 16, 37, 42) . In the calbindin-D 9k gene (16) and the clusterin gene (37), Cdx2 binding sites have been localized within the TATA box. A similar ATAAA consensus sequence was identified within the TATA box of the human CRBP II promoter. This sequence is evolutionarily conserved in the rat and mouse CRBP II promoter (Table 2 ).
These observations suggest the hypothesis that CDX2 directly induces CRBP II expression and that retinoic acid could indirectly induce CRBP II expression in differentiated Caco-2 cells by upregulating CDX2 expression. As shown in Fig. 5 , CDX2 expression is indeed upregulated by retinoic acid treatment of 14-day-postconfluent, Caco-2 cells. This increase was detected by RT-PCR after 35 and 45 cycles (Fig. 5) . By densitometry, the increase was estimated to be approximately fourfold. Using previously described human CDX1-specific primers (23), we were unable to detect an amplified fragment when RT-PCR was performed on oligo(dT)-primed cDNA, although a weak band was observed when RT-PCR was performed on cDNA primed with a gene-specific primer (data not shown). However, we were unable to detect any upregulation of the human CRBP II promoter under conditions in which we observed upregulation of the sucrase-isomaltase promoter (Ϫ183HSILuc luciferase reporter plasmid) in preconfluent Caco-2 cells transiently transfected with either a mouse Cdx1 or mouse Cdx2 expression vector (Table 3) . We were only able to carry out the transfection assays using low amounts of the mouse Cdx1 and mouse Cdx2 expression vectors, because we observed significant cell death when we in- Caco-2 cells were cotransfected with the control expression vector (pRc/CMV), the Cdx2 expression vector (pRc/CMV-Cdx2), or the Cdx1 expression vector (pRc/CMV-Cdx1) as described in MATERIALS AND METHODS. Transfections were carried out with 1 g of the control vector (pRy/CMV), 50 ng of pRc/CMV Cdx2 (with the addition of 0.95 g of pRc/CMV), and 50 ng of pRc/CMV Cdx1 (with the addition of 0.95 g of pRc/CMV). The luciferase activity of the reporter cotransfected with pRc/CMV in the absence of ligand is taken as 1. The basal level of phCRBP II
-luc was 50-fold higher than that of the promotorless pGL2 vector in Caco-2 cells. The basal level of Ϫ183HSILuc was 2-fold higher than that of pGL2 in Caco-2 cells. The results are the average (Ϯ 15%) of 3 independent triplicated transfections. Fig. 4 . Northern blot analysis of the effect of 9-cis-retinoic acid on CRBP II and EGFP-1 mRNA levels in postconfluent, differentiated Caco-2 cells stably transfected with phCRBP II Ϫ2,742-ϩ58 -EGFP-1. EGFP mRNA was measured to measure the human CRBP II promoter activity of the EGFP-1 reporter construct. Endogenous human CRBP II mRNA levels were measured using a rat CRBP II cDNA probe to measure endogenous human CRBP II promoter activity. The CRBP II and EGFP data were normalized to the corresponding GAPDH signal, with the units for vehicle alone set to 1 (* P Ͻ 0.02).
creased the concentration of the expression vectors further (0.5-1.0 g).
DISCUSSION
CRBP II expression is limited to the villus absorptive cells of the proximal intestine in the adult animal (5) . Its expression in Caco-2 cells is associated with differentiation of the cells after they reach confluence (17, 31) . Differentiated Caco-2 cell monolayers incubated in the presence of retinoic acid have increased human CRBP II expression and increased retinol uptake compared with monolayers incubated in the absence of retinoids (11) . Since a RXR-specific agonist but not a RAR-specific agonist increased human CRBP II expression, activation of RXR but not RAR is involved in the upregulation. However, sequence analysis and cotransfection experiments with RXR expression vectors indicate that the retinoic acid inducibility occurs independent of the direct effect of RXR on the human CRBP II promoter, in contrast to the rat CRBP II promoter. Furthermore, retinoic acid inducibility of the human CRBP II promoter is observed only in postconfluent differentiated Caco-2 cells and not in proliferating undifferentiated Caco-2 cells.
Upregulation of the CRBP II promoter associated with Caco-2 cell monolayers is observed even when the promoter was truncated to within 103 bp upstream of the transcriptional start site. The results suggest that retinoic acid upregulation of human CRBP II expression in postconfluent differentiated Caco-2 cells occurs via an indirect mechanism, and the mechanism is linked with enterocyte differentiation. RXR-␣ mRNA levels are detectable in Caco-2 cells at 70% confluence but are 1.6-fold greater by 14 days postconfluence (28) . Retinoic acid treatment does not alter RXR-␣ mRNA levels in postconfluent differentiated Caco-2 cells (11, 28) . Since overexpression of RXR-␣ did not restore retinoic acid inducibility of the human CRBP II promoter in undifferentiated proliferating Caco-2 cells, it is unlikely that the increased RXR-␣ levels in postconfluent Caco-2 cells are sufficient to account for the retinoic acid responsiveness observed with differentiation. Other nuclear receptors, such as hepatocyte nuclear factor 4 (HNF-4) and apolipoprotein AI regulatory protein (ARP-1), have been shown to compete with RAR and RXR for RE3 in the mouse and rat CRBP II promoters (28) . HNF-4 is expressed in the small intestine as well as the liver, kidney, and pancreas (34) . HNF-4 mRNA levels are increased in differentiated Caco-2 cells but are not modulated by retinoic acid treatment (11) . Furthermore, overexpression of HNF-4 has been shown to diminish retinoic acid responsiveness of the mouse and rat CRBP II promoters. Thus it is unlikely that HNF-4 serves as an intermediary for conferring retinoic acid responsiveness to the human CRBP II gene.
Retinoic acid treatment of differentiated Caco-2 cells resulted in increased human CDX2 expression. The evolutionarily conserved region of the human CRBP II promoter contains a potential cdx2 binding site ATAAA within the TATA box. Of note, this consensus sequence is also present in the TATA box of the promoters of two homologous proteins that are expressed in the small intestinal villus absorptive cells: intestinal fatty acid binding protein and liver fatty acid binding protein. This consensus sequence is not present in the promoter of a highly homologous CRBP, which is not expressed in intestinal epithelial cells (21) . However, despite increased expression of a human sucrase-isomaltase reporter, expression of the human CRBP II luciferase reporter construct was not increased when mouse cdx1 or cdx2 was overexpressed in undifferentiated Caco-2 cells. The achievable levels of mouse cdx1 or cdx2 expression in undifferentiated Caco-2 cells were limited by reduced cell viability when cells were transfected with greater quantities of the expression vectors. Since differentiation of intestinal cells affects cdx2 signaling pathways by altering cdx2 phosphorylation (12) , it is also possible that hypophosphorylation of overexpressed mouse cdx2 in undifferentiated preconfluent Caco-2 cells limited its transcriptional activity.
In summary, we have cloned and sequenced 2.8 kb of the human CRBP II promoter and have found that the rat CRBP II RXRE is not conserved in this segment of human CRBP II promoter. Retinoic acid upregulation of human CRBP II promoter activity is not induced by retinoic acid in transiently transfected undifferentiated Caco-2 cells but is observed in stably transfected differentiated Caco-2 cells. These results suggest that retinoic acid upregulation of human CRBP II promoter activity is mediated indirectly by an intermediary, which is also dependent on enterocyte differentiation.
